Peptide Therapy for Injury Recovery
Peptide therapy for injury recovery refers to the use of specific peptides and peptide-like compounds that are being studied for their potential to influence tissue repair, inflammation balance, collagen remodelling, immune signalling, circulation, and recovery capacity. Peptides are short chains of amino acids that act like biological messengers, helping coordinate signals between cells, hormones, and organ systems during healing and adaptation.
Category 1: Tissue Repair & Soft-Tissue Remodelling Peptides
BPC-157
What it Is
BPC-157 is a synthetic 15–amino-acid peptide studied for tissue-protective and repair-related effects in experimental systems.
How it Works
BPC-157 has been associated with changes that support cell movement and survival under stress, including signalling consistent with enhanced migration and attachment. Some studies report activity linked to the FAK–paxillin pathway (important for cell adhesion/migration) and increased growth hormone receptor expression in tendon fibroblasts, which could affect how cells respond to regenerative signals.
Potential Benefits
May influence tendon healing characteristics, connective tissue remodelling, angiogenesis-related signalling, and the balance of inflammatory mediators. These effects are exploratory, and they do not confirm predictable outcomes in humans.
Typical Use Cases/Goals
Tendon/ligament injury models, wound-healing biology, and musculoskeletal recovery frameworks.
TB-500 (Thymosin β4 fragment)
What it Is
TB-500 is commonly marketed as a thymosin β4–related peptide fragment; thymosin β4 is a naturally occurring peptide involved in actin dynamics and cellular movement.
How it Works
Thymosin β4 is linked to repair-related processes, including cell migration, angiogenesis signalling, and tissue remodelling. steps that are central to wound healing and connective tissue recovery.
Potential Benefits
It may influence the coordination of soft-tissue remodelling and repair signalling, affecting how cells move into an injured area and reorganize the extracellular matrix.
Typical Use Cases/Goals
Wound repair, tissue remodelling, and recovery narratives centered on mobility and connective tissue support.
GHK-Cu
What it Is
GHK-Cu is a copper-binding tripeptide studied for roles in tissue remodelling and skin/connective tissue health.
How it Works
Copper binding is relevant because copper participates in enzymes involved in connective tissue structure and repair, and GHK-Cu has been discussed in relation to gene-expression patterns tied to extracellular matrix organization.
Potential Benefits (Under Research)
It may influence connective tissue remodelling and skin repair features, with potential relevance to recovery narratives where tissue quality and remodelling matter.
Typical Use Cases/Goals
Dermatologic repair, connective tissue remodelling, and “healing support” biology.
Category 2: Inflammation & Wound-Microenvironment Signalling Peptides
KPV
What it Is
KPV is a short peptide fragment associated with α‑MSH (alpha-melanocyte stimulating hormone) signalling, studied for immunomodulatory effects.
How it Works
α‑MSH-related fragments can influence cytokine signalling and immune cell behaviour, which may affect local inflammatory tone at tissues and barrier surfaces. KPV is generally framed as supporting a balanced immune environment rather than “turning off” inflammation entirely.
Potential Benefits
It may influence inflammatory mediator patterns and support barrier/immune signalling.
Typical Use Cases/Goals
Inflammatory signalling research (often skin/gut contexts) and recovery discussions where excessive inflammation is a concern.
LL-37
What it Is
LL-37 is a naturally occurring human antimicrobial peptide involved in innate immune defence and wound-related signalling.
How it Works
LL-37 can directly disrupt microbial membranes and also shape immune signalling and cell recruitment in tissue microenvironments, which is why it appears in wound and post-injury discussions.
Potential Benefits
It may influence wound microenvironment signalling and local defence mechanisms; clinical recovery benefits are not established as predictable outcomes.
Typical use Cases/Goals Discussed in Research
Wound biology, innate immunity, and inflammation-related microenvironment studies.
Category 3: GH / IGF-1 Axis Peptides & Recovery Physiology
IGF-1 LR3
What it Is
IGF‑1 LR3 is a long-acting analog of insulin-like growth factor‑1 (IGF‑1), a hormone involved in growth and tissue remodelling.
How it Works
It activates IGF‑1 receptors, influencing pathways related to cell growth, protein synthesis, and tissue turnover; modifications are intended to extend activity compared with native IGF‑1.
Potential Benefits
It may influence anabolic signalling and muscle remodelling.
Typical Use Cases/Goals
Growth-factor physiology, catabolic states, and muscle adaptation.
PEG-MGF
What it Is
PEG‑MGF is described as a pegylated “mechano growth factor” concept related to IGF‑1 splice-variant signalling discussed in muscle repair biology.
How it Works
It is theorized to influence regeneration signalling linked to mechanical stress and repair, with pegylation used to prolong circulation time.
Potential Benefits
It may influence muscle recovery pathways.
Typical Use Cases/Goals
Muscle regeneration biology and exercise-adaptation signalling models.
CJC-1295
What it Is
CJC‑1295 is a long-acting analog of growth hormone–releasing hormone (GHRH) designed to extend signalling time in the body.
How it Works
By stimulating the pituitary, it may increase pulsatile growth hormone release and downstream IGF‑1 levels, which can influence body composition and tissue turnover over time.
Potential Benefits
Research suggests it can raise GH/IGF signalling, which may influence recovery physiology and remodelling capacity.
Typical Use Cases/Goals
GH-axis research, age-related endocrine change, and body composition studies.
Ipamorelin
What it Is
Ipamorelin is a growth hormone secretagogue that activates the ghrelin receptor (GHSR) to stimulate GH release.
How it Works
It promotes GH secretion via hypothalamic–pituitary signaling, potentially affecting downstream IGF-related pathways involved in tissue turnover. Because it alters endocrine signalling, effects can be systemic rather than injury-specific.
Potential Benefits
It may influence recovery capacity indirectly through GH/IGF signalling, though direct evidence of accelerated tissue healing in humans is limited.
Typical Use Cases/Goals
GH secretagogue research, catabolic states, and recovery/aging frameworks.
Sermorelin
What it Is
Sermorelin is a peptide analog of growth hormone–releasing hormone (GHRH).
How it Works
It stimulates the pituitary to release endogenous GH, aiming to support a physiologic pulsatile pattern of secretion. This can influence downstream IGF signalling and broader metabolic recovery parameters.
Potential Benefits
It may influence recovery physiology tied to GH/IGF pathways.
Typical use cases/goals
GH-axis evaluation and endocrine support discussions.
Tesamorelin
What it is
Tesamorelin is a synthetic GHRH analog with clinical research and approved use in certain regions for specific indications (notably visceral adiposity in defined populations).
How it Works
It increases endogenous GH release and raises IGF‑1, which can shift metabolic parameters and influence tissue turnover.
Potential Benefits
It may influence visceral fat and metabolic markers.
Typical use cases/goals
Metabolic health endpoints (including visceral adiposity) and selected patient populations.
Hexarelin
What it Is
Hexarelin is an older growth hormone secretagogue that activates the ghrelin receptor (GHSR).
How it Works
It stimulates GH release and influences downstream endocrine and metabolic pathways; effects can include changes in appetite and metabolism.
Potential Benefits
It may influence anabolic signalling and recovery physiology.
Typical use cases/goals
Endocrine research on GH release and metabolism.
Category 4: Mitochondrial & Cellular-Energy Modulators
MOTS-C
What it is
MOTS‑C is a mitochondrial-derived peptide studied for roles in metabolism and cellular stress response.
How it works
Research suggests it may influence pathways involved in glucose handling and metabolic adaptation (often discussed alongside AMPK-related signaling), which can affect how tissues respond to energetic stress.
Potential Benefits
It may influence insulin sensitivity, metabolic flexibility, and exercise-related resilience.
Typical use cases/goals
Obesity and insulin resistance models, exercise physiology, and aging-related metabolic studies.
NAD+ (and NAD+-focused therapies; not a peptide)
What it is
NAD+ (nicotinamide adenine dinucleotide) is a cellular cofactor essential for energy production and repair-related enzymatic processes. “NAD+ therapy” may refer to direct NAD+ approaches or precursors that raise NAD+ levels.
How it Works
NAD+ supports mitochondrial redox reactions and is used by enzymes involved in stress response and DNA repair signalling.
Potential Benefits
Some studies show that NAD+ levels can be increased with certain interventions that may affect metabolic markers.
Typical use cases/goals
Healthy aging, metabolic health, fatigue, and cellular stress resilience.
Peptide | Category / Focus | Main mechanism described in research (high level) | Typical research goals* |
BPC-157 | Tissue repair / inflammation | Repair-related signalling in fibroblasts; migration/survival pathways; tendon healing in animals | Tendon/ligament/muscle models; wound healing; recovery biology |
TB-500 | Tissue remodeling | Extrapolated thymosin β4 biology (cell migration, remodelling, repair coordination) | Wound/tissue remodelling models; soft-tissue recovery concepts |
GHK-Cu | Connective tissue remodelling | Copper-binding peptide linked to extracellular matrix and remodelling signals | Skin/connective tissue repair; remodelling biology |
KPV | Immune signaling | α‑MSH fragment; cytokine/inflammation signalling modulation (model systems) | Inflammation modulation; barrier/immune signalling |
LL-37 | Post-wound / innate immunity | Antimicrobial + immune signalling in wound microenvironments | Wound biology; innate defence signaling |
PEG-MGF | Muscle repair signaling | IGF-related regeneration signalling concept; prolonged exposure via pegylation | Muscle regeneration/adaptation models |
IGF-1 LR3 | Growth factor axis | IGF‑1 receptor signalling affecting growth/protein synthesis pathways | Catabolic states; muscle remodelling physiology |
CJC-1295 | GH axis | GHRH analog; stimulates GH pulses and downstream IGF‑1 | Endocrine/body composition research |
Ipamorelin | GH secretagogue | GHSR (ghrelin receptor) agonism; GH release stimulation | GH secretagogue research; recovery physiology |
Sermorelin | GH axis | GHRH analog; pituitary GH stimulation | GH-axis support research |
Tesamorelin | GH axis / metabolism | GHRH analog; GH/IGF shift with metabolic effects | Metabolic endpoints; selected clinical populations |
Hexarelin | GH secretagogue | GHSR agonism; GH release + metabolic signalling shifts | Endocrine physiology studies |
MOTS-C | Mitochondrial peptide | Metabolic stress signalling; energy utilization pathways | Metabolic resilience; exercise/aging research |
NAD+ | Cellular energy (non-peptide) | Redox cofactor for energy production + repair enzymes | Metabolic health; stress resilience; aging research |
